Skip to main content

People Transfer: Jul 8, 2009


General Patent Corporation, an intellectual property firm focused on patent licensing, enforcement, and valuation, said recently that Bruce Lehman and Jack Granowitz have joined the company's advisory board of directors.

Lehman previously served as assistant secretary of commerce, director of the US Patent and Trademark Office, and commissioner of patents and trademarks from 1993 to 1998. He is chairman of the International Intellectual Property Institute, a non-profit IP think tank he founded in Washington, DC, in the late 1990s. Lehman is also a senior counsel for the Baltimore, Md.-based law firm Whiteford Taylor Preston. He holds bachelor's and JD degrees from the University of Wisconsin.

Granowitz was one of the founders of the technology transfer office at Columbia University, and served as its executive director from 1998 to 2000. Prior to joining Columbia, Granowitz was vice president and general manager of the international division of IPCO, and also held executive positions at American Cyanamid and Pfizer. He holds bachelor's and master's degrees in chemical engineering from New York University; and an MBA from Iona College.

The Scripps Research Institute has appointed Scott Forrest as its new director of business and technology development.

Forrest joins Scripps from the University of North Carolina, Chapel Hill, where he most recently served as assistant director of the Office of Technology Development, after working as an associate in the office. During this time, Forrest also held an adjunct faculty position at the UNC-Chapel Hill Kenan-Flagler Business School.

Forrest earned a BS in biochemistry from the University of Calgary in 1999 and a PhD in pharmacology from the University of Virginia in 2004. During his doctoral work, he also worked for the UVA Patent Foundation from 2003 to 2004.

Edward Eisenstein has been appointed as acting president of the University of Maryland Biotechnology Institute, the institute said last week. He will succeed Jennie Hunter-Cevera, who resigned as president on June 30.

Eisenstein previously served as director and research scientists at UMBI's Center for Advanced Research in Biotechnology. He first joined CARB as an assistant professor in 1989. His research interests include structural metabolic engineering and technology for measuring protein interactions.

He holds a PhD in biochemistry from Saint Joseph's University.

Saint Joseph's Translational Research Institute, the research division of Saint Joseph's Health System, has appointed Jai Pal Singh as chief scientific officer.

Singh has more than 22 years of experience in the pharmaceutical and biotechnology industry, particularly in drug discovery and small molecule development, SJTRI said.
He was most recently employed by Eli Lilly, where he served as head of vascular therapeutics research and research advisor for the atherosclerosis-metabolic drug team.

Singh completed his undergraduate and master's degree in science in India, and holds a PhD in biochemistry from the University of Wisconsin, Madison. He also completed his postdoc at Harvard University Medical School.

SJTRI, located in Atlanta, is a private, non-profit research institute that combines the functions of a commercial contract research organization with those of an academic institution, the institute said.

Stephen Fleming has been named vice provost of Georgia Tech’s Enterprise Innovation Institute, the nation’s largest and most comprehensive university-based program of assistance to business and industry, the institute said this week.

Fleming will succeed Wayne Hodges, who retired recently after a 40-year career at Georgia Tech.

Since 2005 Fleming has served as Georgia Tech’s chief commercialization officer and led the Enterprise Innovation Institute’s Commercialization Services Division in creating new companies based on research discoveries.

Fleming has more than 13 years of private equity experience at the general partner level. Prior to his venture capital career, he spent 15 years in operations roles at AT&T Bell Laboratories, Nortel Networks, and LICOM.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.